How many insider trades does FilingIQ track for TYRA?

FilingIQ tracks 248 Form 4 insider transactions for TYRA (Tyra Biosciences, Inc.), covering filings from Sep 17, 2021 onwards. 4 of those are dated within the last 90 days.

Are TYRA insiders net buyers or net sellers?

Across the full Form 4 history for TYRA, 15 transactions (6%) were open-market purchases and 134 (54%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TYRA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is TYRA in?

Tyra Biosciences, Inc. (TYRA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.49B.

TYRA insider trading

Healthcare

Tyra Biosciences, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

248

Last 90 days

Buys / sells

6% / 54%

Market cap

$1.49B

About Tyra Biosciences, Inc.

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.

Company website: tyra.bio

TYRA insider activity at a glance

FilingIQ tracks 248 insider transactions for TYRA in filings since Sep 17, 2021. The most recent transaction is dated Sep 15, 2026.

Across the full history, 15 open-market purchases and 134 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TYRA insider trades is 55.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TYRA trades on FilingIQ Raw filings on SEC EDGAR

Latest TYRA Form 4 filings

RA CAPITAL MANAGEMENT, L.P.

P Sep 17, 2026

Harris Todd President and CEO

A Sep 17, 2026

Rueb Yuliya Vice President, Finance (PAO)

A Sep 17, 2026

Fuhrman Alan Chief Financial Officer

A Sep 17, 2026

Verjee Rehan

P Sep 11, 2026

RA CAPITAL MANAGEMENT, L.P.

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Frequently asked

How many insider trades does FilingIQ track for TYRA?: FilingIQ tracks 248 Form 4 insider transactions for TYRA (Tyra Biosciences, Inc.), covering filings from Sep 17, 2021 onwards. 4 of those are dated within the last 90 days.
Are TYRA insiders net buyers or net sellers?: Across the full Form 4 history for TYRA, 15 transactions (6%) were open-market purchases and 134 (54%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TYRA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is TYRA in?: Tyra Biosciences, Inc. (TYRA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.49B.

Methodology & sources

Every TYRA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.